AU2001286499A1 - Transfusion medicine leukodepletion filter devices as a source of genetic material for genotyping studies - Google Patents

Transfusion medicine leukodepletion filter devices as a source of genetic material for genotyping studies

Info

Publication number
AU2001286499A1
AU2001286499A1 AU2001286499A AU8649901A AU2001286499A1 AU 2001286499 A1 AU2001286499 A1 AU 2001286499A1 AU 2001286499 A AU2001286499 A AU 2001286499A AU 8649901 A AU8649901 A AU 8649901A AU 2001286499 A1 AU2001286499 A1 AU 2001286499A1
Authority
AU
Australia
Prior art keywords
source
genetic material
filter devices
transfusion medicine
genotyping studies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001286499A
Other languages
English (en)
Inventor
Matthew Baker
Neil J. Butt
Galine N. Fomovskaia
Mikhail A. Fomovsky
Martin A Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Global Life Sciences Solutions USA LLC
Original Assignee
Whatman Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whatman Inc filed Critical Whatman Inc
Publication of AU2001286499A1 publication Critical patent/AU2001286499A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1017—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001286499A 2000-08-16 2001-08-15 Transfusion medicine leukodepletion filter devices as a source of genetic material for genotyping studies Abandoned AU2001286499A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22585400P 2000-08-16 2000-08-16
US60/225,854 2000-08-16
PCT/US2001/025570 WO2002014560A1 (en) 2000-08-16 2001-08-15 Transfusion medicine leukodepletion filter devices as a source of genetic material for genotyping studies

Publications (1)

Publication Number Publication Date
AU2001286499A1 true AU2001286499A1 (en) 2002-02-25

Family

ID=22846519

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001286499A Abandoned AU2001286499A1 (en) 2000-08-16 2001-08-15 Transfusion medicine leukodepletion filter devices as a source of genetic material for genotyping studies

Country Status (4)

Country Link
US (1) US6670128B2 (de)
EP (1) EP1337670A4 (de)
AU (1) AU2001286499A1 (de)
WO (1) WO2002014560A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2288760T3 (es) 1996-04-25 2008-01-16 Bioarray Solutions Ltd. Ensamblaje electrocinetico controlado por luz de particulas proximas a superficies.
GB2363381B (en) * 2000-06-12 2004-11-24 Cambridge Molecular Tech Solution
WO2001098765A1 (en) 2000-06-21 2001-12-27 Bioarray Solutions, Ltd. Multianalyte molecular analysis
US9709559B2 (en) 2000-06-21 2017-07-18 Bioarray Solutions, Ltd. Multianalyte molecular analysis using application-specific random particle arrays
US7262063B2 (en) 2001-06-21 2007-08-28 Bio Array Solutions, Ltd. Directed assembly of functional heterostructures
ES2661167T3 (es) 2001-10-15 2018-03-27 Bioarray Solutions Ltd. Análisis multiplexado de loci polimórficos mediante consulta simultánea y detección mediada por enzimas
US7745180B2 (en) 2002-04-24 2010-06-29 Hitachi Chemical Co., Ltd. Device and method for high-throughput quantification of mRNA from whole blood
WO2003091407A2 (en) * 2002-04-24 2003-11-06 Hitachi Chemical Research Center, Inc. Device and method for high-throughput quantification of mrna from whole blood
US7526114B2 (en) 2002-11-15 2009-04-28 Bioarray Solutions Ltd. Analysis, secure access to, and transmission of array images
WO2005029705A2 (en) 2003-09-18 2005-03-31 Bioarray Solutions, Ltd. Number coding for identification of subtypes of coded types of solid phase carriers
US7595279B2 (en) 2003-09-22 2009-09-29 Bioarray Solutions Ltd. Surface immobilized polyelectrolyte with multiple functional groups capable of covalently bonding to biomolecules
CA2544041C (en) 2003-10-28 2015-12-08 Bioarray Solutions Ltd. Optimization of gene expression analysis using immobilized capture probes
AU2004287069B2 (en) 2003-10-29 2009-07-16 Bioarray Solutions, Ltd. Multiplexed nucleic acid analysis by fragmentation of double-stranded DNA
US20050208501A1 (en) * 2004-03-16 2005-09-22 Ambion, Inc. Process and reagents for extraction of RNA from fractionated blood leukocytes
JP2005274368A (ja) * 2004-03-25 2005-10-06 Nippon Sheet Glass Co Ltd バイオチップ用基板
US7848889B2 (en) 2004-08-02 2010-12-07 Bioarray Solutions, Ltd. Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
US8486629B2 (en) 2005-06-01 2013-07-16 Bioarray Solutions, Ltd. Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation
DE102005040259A1 (de) * 2005-08-24 2007-03-01 Qiagen Gmbh Verfahren zur Gewinnung von Nukleinsäuren aus Blut
US20100062518A1 (en) * 2008-09-09 2010-03-11 Sukanta Banerjee Concentrating White Blood Cells for DNA Extraction from a Leukodepleted Blood Sample
WO2010039802A2 (en) * 2008-09-30 2010-04-08 Northwestern University Methods and compositions for isolating nucleic acid
US20110223588A1 (en) * 2010-03-09 2011-09-15 Biosample Llc Solid Phase Nucleic Acid Extraction From Small Sample Volumes, and Release of Controlled Quantities
US8774488B2 (en) * 2010-03-11 2014-07-08 Cellscape Corporation Method and device for identification of nucleated red blood cells from a maternal blood sample
US20160097097A1 (en) 2014-10-02 2016-04-07 Lung-Chih YU Method for determining p1/p2 blood type and detection kit thereof
US9782707B2 (en) 2014-03-24 2017-10-10 Fenwal, Inc. Biological fluid filters having flexible walls and methods for making such filters
US9796166B2 (en) 2014-03-24 2017-10-24 Fenwal, Inc. Flexible biological fluid filters
US9968738B2 (en) 2014-03-24 2018-05-15 Fenwal, Inc. Biological fluid filters with molded frame and methods for making such filters
US10376627B2 (en) 2014-03-24 2019-08-13 Fenwal, Inc. Flexible biological fluid filters
US10159778B2 (en) 2014-03-24 2018-12-25 Fenwal, Inc. Biological fluid filters having flexible walls and methods for making such filters
WO2016052386A1 (ja) * 2014-09-30 2016-04-07 東洋紡株式会社 核酸の分離精製方法および固相担体、デバイス、キット

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
DE4143639C2 (de) * 1991-12-02 2002-10-24 Qiagen Gmbh Verfahren zur Isolierung und Reinigung von Nukleinsäuren
JPH06507078A (ja) 1992-02-10 1994-08-11 バクスター、インターナショナル、インコーポレイテッド ウイルス汚染について血液単位を試験するための方法
US5663045A (en) 1993-03-24 1997-09-02 Baxter International Inc. Method for testing blood units for viral contamination
DE69433425T2 (de) 1993-08-30 2004-10-07 Promega Corp Zusammensetzungen und verfahren zur reinigung von nukleinsäuren
US6268119B1 (en) * 1997-01-24 2001-07-31 Asahi Medical Co., Ltd. Method for separating cells
US6103192A (en) * 1997-04-14 2000-08-15 Genetec Corporation Immobilizing and processing specimens on matrix materials for the identification of nucleic acid sequences
AU6114199A (en) * 1998-10-09 2000-05-01 Whatman Bioscience Limited Isolation method for nucleic acid and apparatus
US6337026B1 (en) * 1999-03-08 2002-01-08 Whatman Hemasure, Inc. Leukocyte reduction filtration media

Also Published As

Publication number Publication date
US6670128B2 (en) 2003-12-30
EP1337670A1 (de) 2003-08-27
US20020090623A1 (en) 2002-07-11
EP1337670A4 (de) 2004-07-14
WO2002014560A9 (en) 2003-03-27
WO2002014560A1 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
AU2001286499A1 (en) Transfusion medicine leukodepletion filter devices as a source of genetic material for genotyping studies
AU2001243205A1 (en) Syringe holder attachment for medication
AU2002323044A1 (en) Delivering material to a patient
AU2001270367A1 (en) Cannula for use with a medical syringe
AU5774500A (en) Syringe for transfer of medication from a prefilled medication container
HK1079986A1 (en) Process for preparation of a sterile suspension ofcorticosteroid particles for the administration b y inhalation
AU2001241423A1 (en) Needleless syringe
AU2001261425A1 (en) Cases for medication delivery devices
AU2001276860A1 (en) Medicaments for chemotherapeutic treatment of disease
AUPR553701A0 (en) A device for the delivery of a drug to a fractured bone
AU2001264193A1 (en) Priming device for medical infusion systems
AU3052700A (en) Medico-surgical discharge cannula
AUPS135702A0 (en) A medical syringe container
AU2002357935A1 (en) Dosage form for providing time-varying patterns of drug delivery
AU2002231927A1 (en) Use of rhein for preparing a medicine for treating a high level of il-1
AU3370100A (en) Tampon containing a medicinal liquid imparted from a tampon irrigation syringe
AU2002322082A1 (en) Pharmaceutical composition for the treatment of viral infection
AU1946101A (en) Sterile syringe package
AU2002332836A1 (en) Stabilizing catheter for protein drug delivery
AU2001232053A1 (en) System for the extracorporeal treatment of blood
AU2001254712A1 (en) Use of organophosphorous compounds for producing a medicament for treating infections
AU2002240004A1 (en) Infusion cannula
AU2002361473A1 (en) Unit for delivering a single dosage of a liquid medicine
AU2002210286A1 (en) Medicine intended for treatment of multiple sclerosis
AU2001269263A1 (en) Medicaments containing dextrin for treating respiratory disorders such as cysticfibrosis